Probiotec financials at a glance
| Year | Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$53.99M | $66.07M | $87.13M | $74.77M | $71.77M | $66.05M | $67.34M | $68.21M | $63.31M | $65.61M | $60.65M | $66.44M | $73.24M | $107.22M | $120.51M | $182.33M | $214.03M | $0.00M |
| GM % | Gross Margin % |
|
37.37% | 42.56% | 50.82% | 51.97% | 47.28% | 44.29% | 43.32% | 36.36% | 36.96% | 36.55% | 37.57% | 34.39% | 30.96% | 29.64% | 32.11% | 31.39% | 30.06% | 0.00% |
| OM | Operating Margin |
|
14.46% | 15.51% | 16.09% | 9.70% | 4.25% | 1.01% | 3.33% | -3.51% | 0.84% | 5.46% | 7.13% | 5.96% | 8.23% | 10.10% | 9.14% | 10.72% | 9.69% | 0.00% |
| EPS | Earnings Per Share |
|
$0.13 | $0.18 | $0.20 | $0.02 | $0.06 | $0.11 | $0.12 | $0.17 | $0.16 | $0.00 | ||||||||
| Div. | Dividends |
|
$0.00 | $0.03 | $0.03 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.05 | $0.05 | $0.06 | $0.07 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 23.08% | 16.67% | 20.00% | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 66.67% | 45.45% | 41.67% | 35.29% | 43.75% | 0 |
| Sha. | Shares |
|
46.57m | 48.04m | 48.9m | 52.37m | 52.93m | 52.93m | 56.03m | 52.93m | 52.93m | 52.93m | 52.93m | 60.83m | 61.2m | 74.78m | 78.46m | 81.32m | 81.32m | 81.32m |
| OCF | Operating Cash Flow |
|
$4.46M | $8.21M | $9.01M | $4.92M | $6.32M | $3.54M | $5.44M | $5.31M | $2.32M | $5.04M | $4.09M | $6.22M | $-4.39M | $10.17M | $24.37M | $19.52M | $17.17M | $0.00M |
| FCF | Free Cash Flow |
|
$-4.96M | $3.73M | $2.14M | $1.77M | $4.31M | $0.01M | $-2.59M | $2.71M | $0.52M | $2.45M | $1.58M | $1.62M | $-15.69M | $4.54M | $20.18M | $14.65M | $7.02M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.11 | $0.08 | $0.00 | $-0.17 | $0.04 | $0.06 | $-0.06 | $0.21 | $-0.01 | $0.03 | $0.02 | $0.01 | $0.08 | $0.14 | $0.26 | $0.16 | $0.09 | $0.00 |